ESPR vs WDAY · rev $332.3M vs P/E 135, rev $5.19B
Esperion Therapeutics Inc (ESPR) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
ESPR currently screens at market cap $816.9M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the ESPR and WDAY stock pages for the full models.
Not investment advice.